Unveiling The Hidden Risks Of Sotagliflozin: A Nationwide Pharmacovigilance Analysis Of Adverse Events From The FDA Reporting System

Journal of Cardiac Failure 2026

View at publisher

Authors: Pallavi Matai, Oyindamola Amosu, Daria Chelysheva, Seema Sharma Gautam, Anas Atrash

DOI: 10.1016/j.cardfail.2025.11.270

Cited by: 0

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Diabetes Treatment and Management Pharmacology and Obesity Treatment